AngioDynamics (ANGO) Reports In-Line Q1 EPS, Offers Q2 and FY16 Guidance

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/30/2026

1. INTC
2. AMZN
3. RDDT
4. PINS
5. COIN
6. FSLR
7. SYK
8. MA
9. FND
10. DASH

Go back to AngioDynamics (ANGO) Reports In-Line Q1 EPS, Offers Q2 and FY16 Guidance

AngioDynamics Reports Fiscal 2016 First Quarter Results

October 8, 2015 4:01 PM EDT

Net sales of $83.7 millionGAAP loss of $0.02 per share; Non-GAAP adjusted EPS of $0.11Operating cash generation of $4.7 million Management provides Q2 outlook and reiterates FY2016 guidance

ALBANY, N.Y., Oct. 08, 2015 (GLOBE NEWSWIRE) -- AngioDynamics (NASDAQ: ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular disease and oncology, today reported financial results for the first quarter of fiscal year 2016 ended August 31, 2015.

Today, we... More